← Back
$ALAB All transactions

Astera Labs, Inc.

▼ SELL 10b5-1 Plan

$ Value

$369K

Shares

3,968

Price

$93

Filed

Jun 3

Insider

Name

Tate Michael Truett

Title

Chief Financial Officer

CIK

0001399546

Roles

Officer

Transaction Details

Transaction Date

2025-05-30

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

626,096

Footnotes

The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.5200 to $88.5100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.5200 to $89.5100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.5200 to $90.5100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.5200 to $91.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.5200 to $92.5100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.5400 to $93.0600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.0400 to $94.6000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001628280-25-029091

Form Type

4

Issuer CIK

0001736297

Tate Michael Truett's History

Date Ticker Type Value
2025-09-11 ALAB G $0
2025-08-19 ALAB G $0
2025-08-19 ALAB G $0
2025-08-18 ALAB $1.8M
2025-08-18 ALAB $1.7M
2025-08-12 ALAB $12.7M
2025-08-12 ALAB $6.2M
2025-08-12 ALAB $205K
2025-08-08 ALAB G $0
2025-08-07 ALAB G $0

Other Insiders at ALAB (90d)

Insider Bought Sold Last
ALBA MANUEL $19.7M 2026-04-01
Dyckerhoff Stefan A $4.4M 2026-04-20
Mohan Jitendra
Chief Executive Officer
$76.9M 2026-04-20
Mazzara Philip
General Counsel and Secretary
$1.1M 2026-04-01